Kao (4452) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved strong first-half results with net sales up 2.7% year-over-year to JPY 809 billion and operating income up 19.9% to JPY 69.5 billion, driven by robust performance in Japan and improved profitability in Cosmetics and Hair Care.
Upward revision of full-year operating income forecast to JPY 165 billion and net sales to JPY 1,690 billion, reflecting strong performance and improved earning power.
Shareholder returns enhanced with a share repurchase of up to 15 million shares (JPY 80 billion) and a steady dividend increase.
Progress on mid-term plan K27 is ahead of schedule, with targets for ROIC, EVA, and operating income revised upward.
Financial highlights
Net sales increased 2.7% year-over-year to JPY 809 billion; like-for-like growth was 3.7%.
Operating income rose by JPY 11.5 billion to JPY 69.5 billion, with operating margin improving to 8.6%.
Net income attributable to owners increased 14.3% to JPY 49.6 billion; EPS up 14.4% to JPY 106.85.
Gross margin stable at 38.5% year-over-year; gross profit increased by JPY 8.2 billion to JPY 311.8 billion.
EBITDA for H1 increased 9.7% to JPY 112.2 billion.
Outlook and guidance
Full-year forecasts for net sales and operating income revised upward to JPY 1,690 billion (+3.8% YoY) and JPY 165 billion (+12.5%), with net income projected at JPY 121 billion (+12.3%).
Basic EPS for the year projected at JPY 262.02; dividend forecast raised to JPY 154 per share.
ROE projected to improve by 0.9 points to 11.7%; ROIC target revised to 10.0%.
Continued focus on high value-added products, price adjustments, and global expansion, especially in ASEAN, Europe, China, Cosmetics, and Chemical segments.
Management expects continued uncertainty from global supply chain disruptions, tariff changes, and geopolitical risks.
Latest events from Kao
- Profits and sales rose, with a share split and higher dividends planned for FY2026.4452
Q4 20256 Feb 2026 - H1 operating income up 68%, full-year outlook raised, but China remains a challenge.4452
Q2 20242 Feb 2026 - Profit and margin growth surged on reforms and premiumization, offsetting China cosmetics weakness.4452
Q3 202416 Jan 2026 - Profit and ROIC surged on reforms; 2025 targets further growth and global expansion.4452
Q4 20248 Jan 2026 - Operating income jumped 41.9% on 6.6% sales growth, with robust gains in Japan.4452
Q1 20258 Jan 2026 - Profitability and margins rose, driven by high-value products and Cosmetics recovery.4452
Q3 202516 Dec 2025